Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Influenece of NSAID use and ulcer bleeding on Helicobacter pylori eradication rate in peptic ulcer patients (CROSBI ID 478730)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Filipec, Tajana ; Katičić, Miroslava, Papa, Branko ; Prskalo, Marija ; Tićak, Mirjana ; Šabarić, Branaka ; Čolić-Cvrlje, Vesna ; Naumovski-Mihalić, Slavica ; Škurla, Bruno Influenece of NSAID use and ulcer bleeding on Helicobacter pylori eradication rate in peptic ulcer patients // Gut / Farthing, Micahel J.G. (ur.). London : Delhi: BMJ, 2000. str. 121-x

Podaci o odgovornosti

Filipec, Tajana ; Katičić, Miroslava, Papa, Branko ; Prskalo, Marija ; Tićak, Mirjana ; Šabarić, Branaka ; Čolić-Cvrlje, Vesna ; Naumovski-Mihalić, Slavica ; Škurla, Bruno

engleski

Influenece of NSAID use and ulcer bleeding on Helicobacter pylori eradication rate in peptic ulcer patients

Objective: There are conflicting evidents about interaction between Helicobacter Pylori (HP) and NSAID using on eradication success and ulcers healing. The aim of the study was to investigate possible differences in eradication success of HP in patients using NSAID or bleeding complications in duodenal ulcer (DU), gastric ulcer (GU) or both duodenal ulcer and gastric ulcer (GDU). Methods: 978 patients with DU, GU or GDU entered the study. HP status was confirmed with histology, CLO test, urea breath test (UBT). All of them received eradication therapy. Success was confirmed with histology and/or UBT 4-6 weeks after the therapy ending.127 patiens with GU took NSAID-s, 151 with DU, 16 with GDU before admiting to first endoscopy and treatment for more than 7 days. 125 of patients with DU, 72 with GU and 8 with GDU had bleeding complications. Significance of difference was confirmed with Chy-square test. Results: eradication success + eradication success - GU NSAID + 104 23 p=0.1845 NSAID - 159 51 N.S. bleeding + 59 13 p=0.1600 bleeding - 125 45 N.S. DU NSAID + 123 28 p=0.0030 NSAID - 298 153 S. bleeding + 105 20 p=0.0000 bleeding - 237 142 S. GDU NSAID + 12 4 p=0.5150 NSAID - 15 8 N.S. bleeding + 7 1 p=0.2090 bleeding - 20 11 N.S. Conclusions: HP eradication is significantly more successful in NSAID positive patients with DU, than NSAID negative. The same result of eradication success was seen in bleeding complicated DU. This difference was not seen in GU, or in GDU.

Helicobacter pylori; NSAIL; krvarenje; eradikacija

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

121-x.

2000.

objavljeno

Podaci o matičnoj publikaciji

Gut

Farthing, Micahel J.G.

London : Delhi: BMJ

Podaci o skupu

8th UEGW Brusseles 200

poster

25.11.2000-30.11.2000

Bruxelles, Belgija

Povezanost rada

Javno zdravstvo i zdravstvena zaštita